As anticipated, immunoblot analysis on the tumor samples showed that niraparib treatment induced slight increase of p-γH2AX and cleaved caspase 7 in control tumors, whereas the same treatment led to massive elevation of these markers in the tumors derived from ICMT knockdown cells (Fig 7D). Here, CASP7 is linked to neoplasm.